In the contemporary landscape of clinical skincare, Oligopeptide-1, commonly known as Epidermal Growth Factor (EGF), has emerged as the "Gold Standard" for cellular regeneration. Globally, the demand for high-purity Oligopeptide-1 has transitioned from niche medical applications—such as post-operative wound healing—to the mainstream high-end cosmetic industry. With the rapid expansion of the medical aesthetics market in Europe, North America, and East Asia, the need for stable, bio-active peptides has reached an all-time high.
Current industrial data indicates that the global cosmetic peptide market is expected to grow at a CAGR of over 7.5% through 2030. Oligopeptide-1 stands at the forefront of this growth due to its unparalleled ability to stimulate fibroblast proliferation and collagen synthesis. Manufacturers worldwide are now focusing on Bio-fermentation technology, moving away from traditional synthetic methods to ensure greater biocompatibility and eco-friendliness.
Modern factories utilize E. coli recombinant DNA technology to produce Oligopeptide-1 that mimics the natural human growth factor structure, ensuring 99%+ purity levels.
A Shift toward "Preventative Aging" means younger demographics are now sourcing EGF-enriched products, expanding the market beyond traditional mature skin demographics.
As a leading manufacturer, we strictly adhere to INCI standards, ensuring our peptides are registered and safe for global distribution and formulation.
The industry is currently witnessing a massive shift towards "Smart Peptides". These are targeted delivery systems where Oligopeptide-1 is encapsulated in liposomes or nano-emulsions to penetrate deeper into the dermis. Furthermore, there is a burgeoning trend in "Clean Beauty" where sourcing must be sustainable.
As a custom manufacturer, we have noticed a surge in requests for "Vegan EGF"—peptides derived from plant-based host organisms or advanced synthetic biology. This allows brands to claim "Cruelty-Free" and "Plant-Derived" status while maintaining the high efficacy of traditional Oligopeptide-1.
Founded in 2013 and headquartered in the prestigious high-tech zone of Xi'an, Xi'an Aoge Biotech Co., Ltd., along with its subsidiaries Xi'an Imaherb Biotech Co., Ltd. and Xi'an Nahanutri Biotech Co., Ltd., has established itself as a leading force in the cosmetics raw materials industry.
Our expansive cooperative factory, spanning 1,000 mu (approximately 165 acres), is equipped with state-of-the-art extraction technology. This advanced infrastructure allows us to manufacture a wide array of premium cosmetic raw materials. Our product line includes natural plant extracts specifically designed for organic cosmetics, as well as synthetic ingredients for high-end skincare formulations.
Xi'an has long been the epicenter of botanical extraction and biotechnological innovation in China. Our location allows us access to a robust supply chain and world-class scientific talent from local universities. As a Custom Oligopeptide-1 Manufacturer, we offer:
Global sourcing needs vary by region. In the North American market, there is a high demand for EGF in "clean clinical" formulations. In South Korea, Oligopeptide-1 is often combined with Centella Asiatica for post-laser repair creams. In Europe, the focus is on sustainable sourcing and COSMOS-compliant peptides. We adapt our manufacturing processes to meet these localized regulatory and consumer preference barriers.
Our in-house lab uses advanced instruments like UPLC, HPLC, GC-MS, ICP-MS for quality control, ensuring raw materials meet strict international standards.
Relentless efforts in research and development, exploring novel raw materials and advanced manufacturing techniques.
Rigorous quality control embedded in every step, from raw material sourcing to final product delivery.
Eco-friendly production methods and responsible sourcing to minimize our environmental footprint.
Aogebio Cosmetic
